Cardiex Share Price and Company Fundamentals
Last traded: Last Friday at 4:06 AM
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. It also provides TeleHealth Services, which provides digital, e-commerce, and mobile tools for patients to connect online with health coaches. The company offers its devices and services to hospitals, clinics, research institutions and pharmaceutical companies. CardieX Limited has a strategic collaboration with Blumio Inc. to develop wearable sensor; and a joint development agreement with inHealth to develop hypertension and cardiovascular programs for the products. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia.
|Primary activities||The development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||15 Lime Street Suite 303 Sydney NSW 2000 Australia|
|Phone / Fax||61 2 9874 8761 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Cardiex does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Cardiex.
|Mr. Niall Charles Edgar Cairns||Exec. Chairman||56||179k|
|Mr. Craig R. Cooper||CEO, MD & Exec. Director||446.83k|
|Mr. Jarrod Travers White B.Bus, C.A., CA, CTA||CFO, Joint Company Sec. & Director||8.13k|
|Mr. Chris Dax||VP of Operations & Pres of ATCOR Medical|
|Mr. Antony Sloan||Global Head of Marketing & Communications|
|Mr. ZiHan Lin||VP of Corp. Devel.|
|Mr. Douglas T. Kurschinski||Exec. VP & Head of Global Sales for AtCor Medical Division|
|Dr. Steven Kesten||Chief Medical Officer||62|
|Dr. Mark Gorelick||Chief Product Officer|
|Mr. Nicholas Marshall||Joint Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cardiex is 57.41M and its enterprise value is 53.96M. The enterprise value to revenue ratio of CDX is 9.24.
The CDX's stocks Beta value is 1.91 making it 91% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Cardiex (CDX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cardiex (ASX:CDX) Frequently Asked Questions
1. What is Cardiex's Stock Symbol?
Cardiex trades on ASX under the ticker symbol "CDX".
2. What is Cardiex's stock price today?
One share of CDX stock can currently be purchased for approximately $0.062.
3. How can I contact Cardiex?
Cardiex's mailing address is 15 Lime Street Suite 303 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9874 8761.
4. What is Cardiex's official website?
The official website of Cardiex is http://cardiex.com.
5. Which share registry manages Cardiex's stock?
Cardiex's stock is managed by LINK MARKET SERVICES LIMITED.